Better Living Through Toxicogenomics?

Toxicologists traditionally use animals to test the toxicity of chemicals and other substances. But the brand new field of toxicogenomics, which applies a whole-genome approach to toxicology questions, is changing all that. Still in its infancy, this field is destined to change the way toxicologists think and act, and could even help optimize the drug-development process. "It holds great promise for the future," says Jay Goodman, a Michigan State University toxicologist. "Toxicogenomics is a to

Written byLaura Lane
| 10 min read

Register for free to listen to this article
Listen with Speechify
0:00
10:00
Share

"It holds great promise for the future," says Jay Goodman, a Michigan State University toxicologist. "Toxicogenomics is a tool that can improve the assessment of potential toxicity." Phil Iannaccone, a researcher at Northwestern University Medical School and invited author of a recent Environmental Health Perspective editorial on the new technology,1 agrees: "The hope is that the observed patterns will be characteristic of a class of toxicants, such as polycyclic aromatic hydrocarbons versus peroxysome proliferators. Eventually one might hope for specificity allowing actual identification of the chemical," he says. "For now it is exciting enough that one might be able to determine if an unknown chemical is likely to behave as a certain class of toxicants or not."

The new field is based on the premise that tumors, disease, and other physical responses to toxic chemicals find their origins in gene expression, which depends on the environment—chemical or otherwise. Determining how ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies